Wright Medical Group (WMGI) : Traders are bullish on Wright Medical Group (WMGI) as it has outperformed the S&P 500 by a wide margin of 14.51% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 4.55%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 6.11% in the last 1 week, and is up 19.51% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock. The stock has recorded a 20-day Moving Average of 14.67% and the 50-Day Moving Average is 12.83%.
Wright Medical Group (NASDAQ:WMGI): The stock opened at $21.71 on Friday but the bulls could not build on the opening and the stock topped out at $21.71 for the day. The stock traded down to $20.85 during the day, due to lack of any buying support eventually closed down at $21.01 with a loss of -2.32% for the day. The stock had closed at $21.51 on the previous day. The total traded volume was 2,007,010 shares.
The company Insiders own 9.3% of Wright Medical Group shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -4.18% . Institutional Investors own 98.89% of Wright Medical Group shares. During last six month period, the net percent change held by insiders has seen a change of -5.11%. In a related news,The officer (SVP, Process Improvement) of Wright Medical Group N.V., Walker Jennifer S. sold 1,167 shares at $19.34 on June 2, 2016. The Insider selling transaction had a total value worth of $22,570. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Wright Medical Group, Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients lifestyles. The Company operates through three segments: U.S., International and BioMimetic. The Companys business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Companys products include extremity hardware, foot and ankle hardware, upper extremity hardware and biologics.